These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33975501)

  • 1. Oral Methadone for Patients With Neuropathic Pain Due to Neoplastic Brachial Plexopathy.
    Matsuda Y; Okayama S
    J Palliat Care; 2022 Apr; 37(2):77-82. PubMed ID: 33975501
    [No Abstract]   [Full Text] [Related]  

  • 2. Brachial Plexus Block for Cancer-Related Pain: A Case Series.
    Zinboonyahgoon N; Vlassakov K; Abrecht CR; Srinivasan S; Narang S
    Pain Physician; 2015; 18(5):E917-24. PubMed ID: 26431146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer.
    Haumann J; Geurts JW; van Kuijk SM; Kremer B; Joosten EA; van den Beuken-van Everdingen MH
    Eur J Cancer; 2016 Sep; 65():121-9. PubMed ID: 27494037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of severe neuropathic cancer pain: an illustrative case and review.
    Connolly I; Zaleon C; Montagnini M
    Am J Hosp Palliat Care; 2013 Feb; 30(1):83-90. PubMed ID: 22504863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone for neuropathic pain in adults.
    McNicol ED; Ferguson MC; Schumann R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral C7 transfers: An innovative approach to improving peripheral neuropathic pain after traumatic brachial plexus injury with C5 rupture and avulsion of C6, C7, C8 and T1. A case series study.
    Monsivais JJ
    Clin Neurol Neurosurg; 2020 Apr; 191():105693. PubMed ID: 32035358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial.
    Haumann J; van Kuijk SMJ; Geurts JW; Hoebers FJP; Kremer B; Joosten EA; van den Beuken-van Everdingen MHJ
    Pain Pract; 2018 Mar; 18(3):331-340. PubMed ID: 28691202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain.
    Sotgiu ML; Valente M; Storchi R; Caramenti G; Biella GE
    Pharmacol Res; 2009 Oct; 60(4):284-90. PubMed ID: 19717013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chronic neuropathic pain with methadone: a review of 13 cases.
    Altier N; Dion D; Boulanger A; Choinière M
    Clin J Pain; 2005; 21(4):364-9. PubMed ID: 15951657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of neuropathic pain following traumatic brachial plexus injury with neurolysis and oral gabapentin: A case report.
    Adetoye AO; Aaron OI; Orimolade EA; P Adetifa KA
    Niger J Clin Pract; 2019 Sep; 22(9):1301-1303. PubMed ID: 31489871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
    Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
    Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of methadone in the treatment of chronic neuropathic pain arising from burn injuries: a case-study.
    Altier N; Dion D; Boulanger A; Choinière M
    Burns; 2001 Nov; 27(7):771-5. PubMed ID: 11600260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain.
    Gagnon B; Bruera E
    J Pain Symptom Manage; 1999 Aug; 18(2):120-5. PubMed ID: 10484859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association between Patient Characteristics and Opioid Treatment Response in Neuropathic and Nociceptive Pain due to Cancer.
    Haumann J; van Kuijk SMJ; Joosten EA; van den Beuken-van Everdingen MHJ
    J Palliat Med; 2019 Feb; 22(2):157-163. PubMed ID: 30359202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very-Low-Dose Methadone To Treat Refractory Neuropathic Pain in Children with Cancer.
    Madden K; Bruera E
    J Palliat Med; 2017 Nov; 20(11):1280-1283. PubMed ID: 28609177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Neuropathic Pain in Patients with Traumatic Brachial Plexus Injury: A Multicenter Prospective Hospital-Based Study.
    Ciaramitaro P; Padua L; Devigili G; Rota E; Tamburin S; Eleopra R; Cruccu G; Truini A;
    Pain Med; 2017 Dec; 18(12):2428-2432. PubMed ID: 28340085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer.
    Crosby V; Wilcock A; Corcoran R
    J Pain Symptom Manage; 2000 Jan; 19(1):35-9. PubMed ID: 10687324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
    Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
    Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.